Suchergebnisse - "Vanderwall, Elizabeth R"

PubPharm (12)

1

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2

enthalten in: bioRxiv.org | 2023

von Mast, F. | Fridy, P. | Ketaren, N. | +25

2

Type 2 inflammation reduces SARS-CoV-2 replication in the airway epithelium in allergic asthma through functional alteration of ciliated epithelial cells

enthalten in: The Journal of allergy and clinical immunology | 2023

von Doni Jayavelu, N. | Altman, M. | Benson, B. | +8

3

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication

enthalten in: bioRxiv.org | 2022

von Vanderwall, E. | Barrow, K. | Rich, L. | +7

4

Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children

enthalten in: BMJ open respiratory research | 2022

von Powell, W. | Rich, L. | Vanderwall, E. | +2

5

IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

enthalten in: The Journal of experimental medicine | 2022

von Hale, M. | Netland, J. | Chen, Y. | +17

ErratumIn: J Exp Med. 2022 Sep 5;219(9):. - PMID 36036783

6

Correction : IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

enthalten in: The Journal of experimental medicine | 2022

von Hale, M. | Netland, J. | Chen, Y. | +17

ErratumFor: J Exp Med. 2022 Sep 5;219(9):. - PMID 35938988

7

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication

enthalten in: Scientific reports | 2022

von Vanderwall, E. | Barrow, K. | Rich, L. | +7

UpdateOf: bioRxiv. 2021 Nov 23;:. - PMID 34845445

8

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

enthalten in: eLife | 2021

von Mast, F. | Fridy, P. | Ketaren, N. | +26

UpdateOf: bioRxiv. 2021 Apr 10;:. - PMID 33851164

9

Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication

enthalten in: bioRxiv : the preprint server for biology | 2021

von Vanderwall, E. | Barrow, K. | Rich, L. | +7

UpdateIn: Sci Rep. 2022 Apr 28;12(1):6972. - PMID 35484173

10

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2

enthalten in: bioRxiv : the preprint server for biology | 2021

von Mast, F. | Fridy, P. | Ketaren, N. | +25

UpdateIn: Elife. 2021 Dec 07;10:. - PMID 34874007